References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)4th edn. American Psychiatric Association, Washington, DC 1994
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606–13
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561–71
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361–70
- Hamilton M. A rating scale for depression J Neurol Neurosurg Psychiat. 1960; 23: 56–62
- International Statistical Classification of Diseases and Health Related Problems (The) ICD-10 Second Edition World Health Organisation Geneva 2005.
- Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000; 5: 262–9
- Castrén E. Is mood chemistry?. Nat Rev Neurosci. 2005; 6: 241–6
- Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990; 8: 221–54
- Salvi RJ, Lockwood AH, Burkard R. Neural plasticity and tinnitus. Tinnitus Handbook, RS Tyler. Singular, San Diego 2000; 123–48
- Simpson JJ, Davies WE. A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res. 2000; 145: 1–7
- McKenna L, Hallam RS, Hinchcliffe R. The prevalence of psychological disturbance in neuro-otology outpatients. Clin Otolaryngol. 1991; 16: 452–6
- Baldo P, Doree C, Lazzarini R, Molin P, McFerran DJ. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 2006; 4: CD003853
- Robinson SK, Viirre ES, Stein MB. Antidepressant therapy in tinnitus. Hear Res. 2007;226:221–31. Epub 2006, Sep 14.
- Martinez Devesa P, Waddell A, Perera R, Theodoulou M. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev 2007; 1: CD005233
- Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev 2004 (1):CD003012. Update of: Cochrane Database Syst Rev 2001 (2):CD003012.
- Parnes SM. Current concepts in the clinical management of patients with tinnitus. Eur Arch Otorhinolaryngol. 1997; 254: 406–9
- McQuay HJ, Moore RA. Antidepressants and chronic pain. Br Med J. 1997; 314: 763–4
- Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med. 2001; 111: 54–63
- Møller AR. Similarities between chronic pain and tinnitus. Am J Otol. 1997; 18: 577–85
- Parker G, Roy K, Wilhelm K, Mitchell P. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. J Clin Psychiatry. 2001; 62: 117–25
- Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, et al. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev 2000; 4: CD002791
- Kasper S, Fuger J, Moller HJ. Comparative efficacy of antidepressants. Drugs. 1992; 43(Suppl 2)11–22
- Podoshin L, Ben-David Y, Fradis M, Malatskey S, Hafner H. Idiopathic subjective tinnitus treated by amitriptyline hydrochloride/biofeedback. Int Tinnitus J. 1995; 1: 54–60
- Bayar N, Boke B, Turan E, Belgin E. Efficacy of amitriptyline in the treatment of subjective tinnitus. J Otolaryngol. 2001; 30: 300–3
- Sullivan M, Katon W, Russo J, Dobie R, Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus. Arch Intern Med. 1993; 153: 2251–9
- Dobie RA, Sullivan MD, Katon WJ, Sakai CS, Russo J. Antidepressant treatment for tinnitus patients. Acta Otolaryngol. 1992; 112: 242–7
- Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol. 1993; 14: 18–23
- Katon W, Sullivan M, Russo J, Dobie R, Sakai C. Depressive symptoms and measures of disability: a prospective study. J Affect Disord. 1993; 27: 245–54
- Sullivan M, Katon W, Russo J, Dobie R, Sakai C. Coping and marital support as correlates of tinnitus disability. Gen Hosp Psychiatry. 1994; 16: 259–66
- Mihail RC, Crowley JM, Walden BE, Fishburne JF, Reinwall JE, Zajtchuk JT. The tricyclic trimipramine in the treatment of subjective tinnitus. Ann Otol Rhinol Laryngol. 1988; 97: 120–3
- Dib GC, Kasse CA, Alves de Andrade T, Gurgel Testa JR, Cruz OL. Tinnitus treatment with trazodone. Rev Bras Otorrinolaringol (Engl Ed) 2007; 73: 390–7
- Robinson SK, Viirre ES, Bailey KA, Gerke MA, Harris JP, Stein MB. Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of non-depressed tinnitus subjects. Psychosom Med. 2005; 67: 981–8
- Zoger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2006; 26: 32–9
- Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus: a double-blind study. Arch Otolaryngol Head Neck Surg. 1993; 119: 842–5
- Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with Hypericum extract WS 5570 (St. John's Wort): randomized controlled double-blind non-inferiority trial versus paroxetine. Br Med J. 2005;330:503. Epub 2005, Feb 11.
- Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002; 136: 42–53
- Scripnikov A, Khomenko A, Napryeyenko O; GINDEM-NP Study Group. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomized controlled trial. Wien Med Wochenschr. 2007;157:295–300.
- Hilton M, Stuart E. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2004; 2: CD003852
- Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. Br Med J. 2005; 330: 1202–5
- Andersson G, Porsaeus D, Wiklund M, Kaldo V, Larsen HC. Treatment of tinnitus in the elderly: a controlled trial of cognitive behaviour therapy. Int J Audiol. 2005; 44: 671–5
- Henry JL, Wilson PH. The psychological management of tinnitus: comparison of a combined cognitive educational programme, education alone and a waiting-list control. Int Tinnitus J. 1996; 2: 9–20
- Kröner-Herwig B, Hebing G, van Rijn-Kalkman U, Frenzel A, Schilkowsky G, Esser G. The management of chronic tinnitus: comparison of a cognitive-behavioural group training with yoga. J Psychosom Res. 1995; 39: 153–65
- Kröner-Herwig B, Frenzel A, Fritsche G, Schilkowsky G, Esser G. The management of chronic tinnitus: comparison of an outpatient cognitive-behavioural group training to minimal-contact interventions. J Pyschosom Res. 2003; 54: 381–9
- Rief W, Weise C, Kley N, Martin A. Psychophysiologic treatment of chronic tinnitus: a randomized clinical trial. Psychosom Med. 2005; 67: 833–8
- Zachriat C, Kröner-Herwig B. Treating chronic tinnitus: comparison of cognitive-behavioural and habituation-based treatments. Cogn Behav Ther. 2004; 33: 187–98
- Salah RS, DeQuardo JR, Jibson MD, Carli T, Tandon R. Tinnitus and ECT. Convuls Ther. 1995; 11: 122–5
- Marangell LB, Martinez M, Jurdi RA, Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand. 2007; 116: 174–81
- Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent versus the earlier rTMS studies. Acta Psychiatr Scand. 2007; 116: 165–73
- Kleinjung T, Steffens T, Londero A, Langguth B. Transcranial magnetic stimulation (TMS) for treatment of chronic tinnitus: clinical effects. Prog Brain Res. 2007; 166: 359–67
- Langguth B, Eichhammer P, Zowe M, Marienhagen J, Spiessl H, Hajak G. Neuronavigated transcranial magnetic stimulation and auditory hallucinations in a schizophrenic patient: monitoring of neurobiological effects. Schizophr Res. 2006;84:185–6. Epub, 2006.
- Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol. 1998; 108: 1–16
- Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2007;20:1–28 (Epub ahead of print).
- Been G, Ngo TT, Miller SM, Fitzgerald PB. The use of tDCS and CVS as methods of non-invasive brain stimulation. Brain Res Rev. 2007;56:346–61. Epub 2007 Aug 28.